Evidence map›Paper›PMID 26978122›Full record

ArticleAmerican journal of respiratory cell and molecular biology2016

Inhibition of Lipolysis Ameliorates Diabetic Phenotype in a Mouse Model of Obstructive Sleep Apnea.

Martin Weiszenstein, Larissa A Shimoda, Michal Koc, Ondrej Seda, Jan Polak

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Effect of obstructive sleep apnea on glucose metabolism.European journal of endocrinology · 2022
    Trial
  3. Trial
  4. The mediating role of remnant cholesterol in the association between obstructive sleep apnea and diabetes: insights from two independent datasets.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Adipose tissue as a key player in obstructive sleep apnoea.European respiratory review : an official journal of the European Respiratory Society · 2019
    Review
  16. Intermittent Hypoxia Up-RegulatesInternational journal of molecular sciences · 2019
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Martin Weiszenstein1 Center for Research on Diabetes, Metabolism, and Nutrition, Third Faculty of Medicine.
Larissa A Shimoda3 Division of Pulmonary and Critical Care Medicine, Asthma and Allergy Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
Michal Koc4 Sports Medicine Department, Third Faculty of Medicine, and.
Ondrej Seda5 Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic; and.
Jan Polak1 Center for Research on Diabetes, Metabolism, and Nutrition, Third Faculty of Medicine.
Johns Hopkins University · USCharles University · CZNational Institute of Public Health · CZThird Way · US

Funding

Mechanisms Linking Sleep-Disordered Breathing and Cardiovascular DiseaseRC1HL099952 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI PUNJABI, NARESH M, SHIMODA, LARISSA A. · 2009 to 2010
$1000k
NHLBI NIH HHS F32 HL070578NHLBI NIH HHS RC1 HL099952
6 · The paper itself

Abstract

Obstructive sleep apnea (OSA) is associated with insulin resistance, glucose intolerance, and type 2 diabetes. Causal mechanisms mediating this association are not well defined; however, augmented lipolysis in adipose might be involved. Here, we investigated the effect of acipimox treatment (lipolysis inhibitor) on glucose tolerance and insulin sensitivity in mice exposed to intermittent hypoxia (IH). C57BL6/J mice were exposed for 14 days to IH or control conditions. IH was created by decreasing the fraction of inspired oxygen from 20.9 to 6.5%, 60 times/h. Control exposure was air (fraction of inspired oxygen, 20.9%) delivered at an identical flow rate. Acipimox was provided in drinking water (0.5 g/ml) during exposures. After exposures, intraperitoneal insulin (0.5 IU/kg) and glucose (1 g/kg) tolerance tests were performed, and primary adipocytes were isolated for lipolysis experiments. IH elevated fasting glucose by 51% and worsened glucose tolerance and insulin sensitivity by 33 and 102%, respectively. In parallel, IH increased spontaneous lipolysis by 264%, and reduced epididymal fat mass by 15% and adipocyte size by 8%. Acipimox treatment prevented IH-induced lipolysis and increased epididymal fat mass and adipocyte size by 19 and 10%, respectively. Acipimox fully prevented IH-induced impairments in fasting glycemia, glucose tolerance, and insulin sensitivity. For all reported results, P less than 0.05 was considered significant. Augmented lipolysis contributes to insulin resistance and glucose intolerance observed in mice exposed to IH. Acipimox treatment ameliorated the metabolic consequences of IH and might represent a novel treatment option for patients with obstructive sleep apnea.

Indexed as

LipolysisAdipocytesAdiposityAnimalsDiabetes Mellitus, ExperimentalDisease Models, AnimalFatty AcidsGene Expression RegulationGlucoseHypoxiaInsulinMaleMice, Inbred C57BLPhenotypePyrazinesSignal TransductionacipimoxFatty AcidsGlucoseInsulinPyrazinesdiabetesinsulin resistanceintermittent hypoxialipolysisobstructive sleep apnea

Identifiers

PMID26978122
PMCPMC4979366
OpenAlexW2301058911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.